About
Peptide drug discovery
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyDrug Delivery & FormulationAustralia
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
8
As Collaborator
0
Total Enrollment
190
By Phase
PHASE1/PHASE2: 2PHASE1: 4
By Status
RECRUITING: 4ACTIVE_NOT_RECRUITING: 2NOT_YET_RECRUITING: 1TERMINATED: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06970106Lead Sponsor
Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy
PHASE1/PHASE2Recruiting
21 participants
Started: Sep 30, 2025 · Completed: Jan 1, 2027
NCT06852963Lead Sponsor
A Study of Two Doses of VP-001 Administered Intravitreally in Participants with Confirmed PRPF31 Mutation-Associated Retinal Dystrophy Previously Treated with VP001
PHASE1/PHASE2Not yet recruiting
12 participants
Started: Jun 1, 2025 · Completed: Aug 1, 2027
NCT06714006Lead Sponsor
Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003
PHASE1Recruiting
56 participants
Started: Apr 7, 2025 · Completed: Jan 31, 2026
NCT06461286Lead Sponsor
SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)
PHASE1Recruiting
18 participants
Started: Oct 31, 2024 · Completed: Aug 31, 2025
NCT06455826Lead Sponsor
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)
PHASE1Recruiting
12 participants
Started: Jun 13, 2024 · Completed: Nov 30, 2025
Locations (1)
Headquarters
Nedlands, Australia
Map
Loading map...